UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Seeds Investor LLC

Seeds Investor LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 13.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,849 shares of the healthcare conglomerate’s stock after selling 279 shares during the period. Seeds Investor LLC’s holdings in UnitedHealth Group were worth $935,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. TCM Advisors LLC increased its holdings in UnitedHealth Group by 7.5% in the fourth quarter. TCM Advisors LLC now owns 1,433 shares of the healthcare conglomerate’s stock valued at $725,000 after buying an additional 100 shares during the last quarter. Sagespring Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at approximately $8,860,000. Distillate Capital Partners LLC increased its stake in UnitedHealth Group by 19.7% during the fourth quarter. Distillate Capital Partners LLC now owns 143,861 shares of the healthcare conglomerate’s stock valued at $72,774,000 after purchasing an additional 23,635 shares during the last quarter. Crux Wealth Advisors bought a new position in shares of UnitedHealth Group in the 4th quarter worth about $983,000. Finally, Nicolet Bankshares Inc. grew its position in shares of UnitedHealth Group by 0.9% during the 4th quarter. Nicolet Bankshares Inc. now owns 2,513 shares of the healthcare conglomerate’s stock valued at $1,271,000 after buying an additional 23 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on UNH shares. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Truist Financial upped their price objective on shares of UnitedHealth Group from $610.00 to $660.00 and gave the stock a “buy” rating in a report on Friday. Finally, Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Twenty-one analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $632.85.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Up 0.8 %

NYSE UNH opened at $599.10 on Friday. The stock has a market cap of $548.00 billion, a price-to-earnings ratio of 38.65, a PEG ratio of 1.37 and a beta of 0.61. The firm’s 50 day moving average price is $512.87 and its two-hundred day moving average price is $542.03. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the company posted $5.83 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.40%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.